Mechanisms and Therapy of Liver Cancer, Volume 149, presents the latest information on the incidence and mortality of liver cancer research and how it has gained significant momentum because of its direct causative association with obesity-induced fatty liver disease. The literature on liver cancer is moving fast with exciting, novel findings, providing new insights reflected in the following updated chapters: Introduction and molecular classification of HCC, Signaling Pathways in Liver Cancer, HCV and HCC, NASH and HCC, Microbiome and Metabolic Abnormalities in HCC, Systemic Therapy of Liver Cancer, Immunotherapy of Liver Cancer, and Desmoplastic Tumor Microenvironment and Intrahepatic Cholangiocarcinoma Progression: Mechanisms and Therapeutic Implications.
1. Cover image - p. page_i 2. Title page - p. page_i 3. Table of Contents - p. page_i 4. Copyright - p. page_iv 5. Contributors - p. page_ix 6. Preface - p. page_xi 7. Chapter One: Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification - p. page_1 8. Chapter Two: Signaling pathways in hepatocellular carcinoma - p. page_63 9. Chapter Three: Hepatitis C virus associated hepatocellular carcinoma - p. page_103 10. Chapter Four: NAFLD-related HCC - p. page_143 11. Chapter Five: Atypical immunometabolism and metabolic reprogramming in liver cancer: Deciphering the role of gut microbiome - p. page_171 12. Chapter Six: Systemic therapy of liver cancer - p. page_257 13. Chapter Seven: Immunotherapy in hepatocellular cancer - p. page_295 14. Chapter Eight: Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression - p. page_321
Mechanisms and Therapy of Liver Cancer, Volume 149, presents the latest information on the incidence and mortality of liver cancer research and how it has gained significant momentum because of its direct causative association with obesity-induced fatty liver disease. The literature on liver cancer is moving fast with exciting, novel findings, providing new insights reflected in the following updated chapters: Introduction and molecular classification of HCC, Signaling Pathways in Liver Cancer, HCV and HCC, NASH and HCC, Microbiome and Metabolic Abnormalities in HCC, Systemic Therapy of Liver Cancer, Immunotherapy of Liver Cancer, and Desmoplastic Tumor Microenvironment and Intrahepatic Cholangiocarcinoma Progression: Mechanisms and Therapeutic Implications.
1. Cover image - p. page_i 2. Title page - p. page_i 3. Table of Contents - p. page_i 4. Copyright - p. page_iv 5. Contributors - p. page_ix 6. Preface - p. page_xi 7. Chapter One: Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification - p. page_1 8. Chapter Two: Signaling pathways in hepatocellular carcinoma - p. page_63 9. Chapter Three: Hepatitis C virus associated hepatocellular carcinoma - p. page_103 10. Chapter Four: NAFLD-related HCC - p. page_143 11. Chapter Five: Atypical immunometabolism and metabolic reprogramming in liver cancer: Deciphering the role of gut microbiome - p. page_171 12. Chapter Six: Systemic therapy of liver cancer - p. page_257 13. Chapter Seven: Immunotherapy in hepatocellular cancer - p. page_295 14. Chapter Eight: Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression - p. page_321
